{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T17:50:05Z","timestamp":1769881805052,"version":"3.49.0"},"reference-count":102,"publisher":"Bentham Science Publishers Ltd.","issue":"10","funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI15\/00303"],"award-info":[{"award-number":["PI15\/00303"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008432","name":"Junta de Extremadur","doi-asserted-by":"publisher","award":["GR15026"],"award-info":[{"award-number":["GR15026"]}],"id":[{"id":"10.13039\/501100008432","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008432","name":"Junta de Extremadur","doi-asserted-by":"publisher","award":["IB16170"],"award-info":[{"award-number":["IB16170"]}],"id":[{"id":"10.13039\/501100008432","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2020,3,27]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>The pathophysiology and neurochemical mechanisms of essential\ntremor (ET) are not fully understood, because only a few post-mortem studies have been reported,\nand there is a lack of good experimental model for this disease.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>The main aim of this review is to update data regarding the neurochemical features\nof ET. Alterations of certain catecholamine systems, the dopaminergic, serotonergic,\nGABAergic, noradrenergic, and adrenergic systems have been described, and are the object of\nthis revision.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p> For this purpose, we performed a literature review on alterations of the neurotransmitter\nor neuromodulator systems (catecholamines, gammaaminobutyric acid or GABA,\nexcitatory amino acids, adenosine, T-type calcium channels) in ET patients (both post-mortem\nor in vivo) or in experimental models resembling ET.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results and Conclusion:<\/jats:title>\n<jats:p>The most consistent data regarding neurochemistry of ET are related\nwith the GABAergic and glutamatergic systems, with a lesser contribution of adenosine\nand dopaminergic and adrenergic systems, while there is not enough evidence of a definite\nrole of other neurotransmitter systems in ET. The improvement of harmaline-induced tremor\nin rodent models achieved with T-type calcium channel antagonists, cannabinoid 1 receptor,\nsphingosine-1-phosphate receptor agonists, and gap-junction blockers, suggests a potential\nrole of these structures in the pathogenesis of ET.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929867325666181112094330","type":"journal-article","created":{"date-parts":[[2018,11,12]],"date-time":"2018-11-12T11:40:27Z","timestamp":1542022827000},"page":"1690-1710","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["An Update on the Neurochemistry of Essential Tremor"],"prefix":"10.2174","volume":"27","author":[{"given":"F\u00e9lix Javier","family":"Jim\u00e9nez-Jim\u00e9nez","sequence":"first","affiliation":[{"name":"Section of Neurology, Hospital Universitario del Sureste, Arganda del Rey, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hortensia","family":"Alonso-Navarro","sequence":"additional","affiliation":[{"name":"Section of Neurology, Hospital Universitario del Sureste, Arganda del Rey, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Garc\u00eda-Mart\u00edn","sequence":"additional","affiliation":[{"name":"University Institute of Molecular Pathology Biomarkers, UNEx. ARADyAL Instituto de Salud Carlos III, Caceres, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 A.G.","family":"Ag\u00fandez","sequence":"additional","affiliation":[{"name":"University Institute of Molecular Pathology Biomarkers, UNEx. ARADyAL Instituto de Salud Carlos III, Caceres, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","first-page":"14","volume":"5","author":"Rajput A.H.","year":"1990","unstructured":"Rajput A.H.; Rozdilsky B.; Kish S.; Hornykiewicz O.; Parkinson\u2019s disease association with essential tremor. Mov Disord 1990,5(Suppl. 1),14","journal-title":"Mov Disord"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/mds.24004","volume":"27","author":"Shill H.A.","year":"2012","unstructured":"Shill H.A.; Adler C.H.; Beach T.G.; Lue L.F.; Caviness J.N.; Sabbagh M.N.; Sue L.I.; Walker D.G.; Brain biochemistry in autopsied patients with essential tremor. Mov Disord 2012,27(1),113-117","journal-title":"Mov Disord"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1212\/WNL.52.7.1422","volume":"52","author":"Lee M.S.","year":"1999","unstructured":"Lee M.S.; Kim Y.D.; Im, J.H.; Kim, H.J.; Rinne, J.O.; Bhatia, K.P. 123I-IPT brain study in essential tremor and Parkinson\u2019s disease. Neurology 1999,52,1422-1426","journal-title":"Neurology"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s00702-004-0208-x","volume":"112","author":"Plotkin M.","year":"2005","unstructured":"Plotkin M.; Amthauer H.; Klaffke S.; K\u00fchn A.; L\u00fcdemann L.; Arnold G.; Wernecke K.D.; Kupsch A.; Felix R.; Venz S.; Combined 123I-FP-CIT and 123I-IBZM SPECT for the diagnosis of parkinsonian syndromes: study on 72 patients. J Neural Transm (Vienna) 2005,112(5),677-692","journal-title":"J Neural Transm (Vienna)"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/mds.22870","volume":"25","author":"Isaias I.U.","year":"2010","unstructured":"Isaias I.U.; Marotta G.; Hirano S.; Canesi M.; Benti R.; Righini A.; Tang C.; Cilia R.; Pezzoli G.; Eidelberg D.; Antonini A.; Imaging essential tremor. Mov Disord 2010,25(6),679-686","journal-title":"Mov Disord"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1002\/1531-8257(200005)15:3<503:AID-MDS1013>3.0.CO;2-V","volume":"15","author":"Benamer T.S.","year":"2000","unstructured":"Benamer T.S.; Patterson J.; Grosset D.G.; Booij J.; de Bruin K.; van Royen E.; Speelman J.D.; Horstink M.H.; Sips H.J.; Dierckx R.A.; Versijpt J.; Decoo. D; Van Der Linden, C.; Hadley, D.M.; Doder, M.; Lees, A.J.; Costa, D.C.; Gacinovic, S.; Oertel, W.H.; Pogarel,l O.; Hoeffken, H.; Joseph. K.; Tatsch, K.; Schwarz, J.; Ries, V. Accurate differentiation of parkinsonism and essential tremor using visual assessment of 123I-FP-CIT-SPECT imaging: the 123I-FP-CIT-SPECT study group. Mov Disord 2000,15,503-510","journal-title":"Mov Disord"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/j.1600-0404.2005.00517.x","volume":"112","author":"Wang J.","year":"2005","unstructured":"Wang J.; Jiang Y.P.; Liu X.D.; Chen Z.P.; Yang L.Q.; Liu C.J.; Xiang J.D.; Su H.L.; 99mTc-TRODAT-1 SPECT study in early Parkinson\u2019s disease and essential tremor. Acta Neurol Scand 2005,112(6),380-385","journal-title":"Acta Neurol Scand"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s100720170040","volume":"22","author":"Antonini A.","year":"2001","unstructured":"Antonini A.; Moresco R.M.; Gobbo C.; De Notaris R.; Panzacchi A.; Barone P.; Calzetti S.; Negrotti A.; Pezzoli G.; Fazio F.; The status of dopamine nerve terminals in Parkinson\u2019s disease and essential tremor: a PET study with the tracer [11-C]FE-CIT. Neurol Sci 2001,22(1),47-48","journal-title":"Neurol Sci"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00702-005-0311-7","volume":"113","author":"Breit S.","year":"2006","unstructured":"Breit S.; Reimold M.; Reischl G.; Klockgether T.; W\u00fcllner U.; [(11)C]d-threo-methylphenidate PET in patients with Parkinson\u2019s disease and essential tremor. J Neural Transm (Vienna) 2006,113(2),187-193","journal-title":"J Neural Transm (Vienna)"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1212\/WNL.55.10.1540","volume":"55","year":"2000","unstructured":"A multicenter assessment of dopamine transporter imaging with DOPASCAN\/SPECT in parkinsonism. Neurology Parkinson Study Group2000,55(10),1540-1547","journal-title":"Neurology"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1007\/s00259-012-2232-7","volume":"39","author":"Di Giuda D.","year":"2012","unstructured":"Di Giuda D.; Camardese G.; Bentivoglio A.R.; Cocciolillo F.; Guidubaldi A.; Pucci L.; Bruno I.; Janiri L.; Giordano A.; Fasano A.; Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a 123I-FP-CIT SPECT study. Eur J Nucl Med Mol Imaging 2012,39(12),1937-1948","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1007\/s00702-015-1419-z","volume":"122","author":"Waln O.","year":"2015","unstructured":"Waln O.; Wu Y.; Perlman R.; Wendt J.; Van A.K.; Jankovic J.; Dopamine transporter imaging in essential tremor with and without parkinsonian features. J Neural Transm (Vienna) 2015,122(11),1515-1521","journal-title":"J Neural Transm (Vienna)"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.parkreldis.2017.07.028","volume":"43","author":"Barbagallo G.","year":"2017","unstructured":"Barbagallo G.; Arabia G.; Morelli M.; Nistic\u00f2 R.; Novellino F.; Salsone M.; Rocca F.; Quattrone A.; Caracciolo M.; Sabatini U.; Cherubini A.; Quattrone A.; Thalamic neurometabolic alterations in tremulous Parkinson\u2019s disease: A preliminary proton MR spectroscopy study. Parkinsonism Relat Disord 2017,43,78-84","journal-title":"Parkinsonism Relat Disord"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1212\/WNL.42.8.1554","volume":"42","author":"Brooks D.J.","year":"1992","unstructured":"Brooks D.J.; Playford E.D.; Ibanez V.; Sawle G.V.; Thompson P.D.; Findley L.J.; Marsden C.D.; Isolated tremor and disruption of the nigrostriatal dopaminergic system: an 18F-dopa PET study. Neurology 1992,42(8),1554-1560","journal-title":"Neurology"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1007\/s007020050124","volume":"105","author":"Asenbaum S.","year":"1998","unstructured":"Asenbaum S.; Pirker W.; Angelberger P.; Bencsits G.; Pruckmayer M.; Br\u00fccke T.; [123I]beta-CIT and SPECT in essential tremor and Parkinson\u2019s disease. J Neural Transm (Vienna) 1998,105(10-12),1213-1228","journal-title":"J Neural Transm (Vienna)"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s12149-012-0577-4","volume":"26","author":"Gerasimou G.","year":"2012","unstructured":"Gerasimou G.; Costa D.C.; Papanastasiou E.; Bostanjiopoulou S.; Arnaoutoglou M.; Moralidis E.; Aggelopoulou T.; Gotzamani-Psarrakou A.; SPECT study with I-123-Ioflupane (DaTSCAN) in patients with essential tremor. Is there any correlation with Parkinson\u2019s disease? Ann Nucl Med 2012,26(4),337-344","journal-title":"Ann Nucl Med"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1097\/MNM.0b013e3282f4d307","volume":"29","author":"Isaias I.U.","year":"2008","unstructured":"Isaias I.U.; Canesi M.; Benti R.; Gerundini P.; Cilia R.; Pezzoli G.; Antonini A.; Striatal dopamine transporter abnormalities in patients with essential tremor. Nucl Med Commun 2008,29(4),349-353","journal-title":"Nucl Med Commun"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1002\/mds.22259","volume":"23","author":"Ceravolo R.","year":"2008","unstructured":"Ceravolo R.; Antonini A.; Volterrani D.; Rossi C.; Kiferle L.; Frosini D.; Lucetti C.; Isaias I.U.; Benti R.; Murri L.; Bonuccelli U.; Predictive value of nigrostriatal dysfunction in isolated tremor: a clinical and SPECT study. Mov Disord 2008,23(14),2049-2054","journal-title":"Mov Disord"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.parkreldis.2011.08.025","volume":"18","author":"Coria F.","year":"2012","unstructured":"Coria F.; Gimenez-Garcia M.; Samaranch L.; Mora F.J.; Sampol-Bas C.; Pastor P.; Nigrostriatal dopaminergic function in subjects with isolated action tremor. Parkinsonism Relat Disord 2012,18(1),49-53","journal-title":"Parkinsonism Relat Disord"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/mds.1265","volume":"17","author":"Pirker W.","year":"2002","unstructured":"Pirker W.; Djamshidian S.; Asenbaum S.; Gerschlager W.; Tribl G.; Hoffmann M.; Br\u00fccke T.; Progression of dopaminergic degeneration in Parkinson\u2019s disease and atypical parkinsonism: a longitudinal beta-CIT SPECT study. Mov Disord 2002,17(1),45-53","journal-title":"Mov Disord"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.parkreldis.2004.03.004","volume":"10","author":"Schwartz M.","year":"2004","unstructured":"Schwartz M.; Groshar D.; Inzelberg R.; Hocherman S.; Dopamine-transporter imaging and visuo-motor testing in essential tremor, practical possibilities for detection of early stage Parkinson\u2019s disease. Parkinsonism Relat Disord 2004,10(6),385-389","journal-title":"Parkinsonism Relat Disord"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/0022-510X(77)90237-4","volume":"32","author":"Lenman J.A.","year":"1977","unstructured":"Lenman J.A.; Turnbull M.J.; Reid A.; Fleming A.M.; Urinary monoamine metabolite excretion in disorders of movement. Effects of amantadine and levodopa. J Neurol Sci 1977,32(2),219-225","journal-title":"J Neurol Sci"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s00702-006-0623-2","volume":"114","author":"Pellicano C.","year":"2007","unstructured":"Pellicano C.; Buttarelli F.R.; Circella A.; Tiple D.; Giovannelli M.; Benincasa D.; Colosimo C.; Pontieri F.E.; Dopamine transporter immunoreactivity in peripheral blood lymphocytes discriminates Parkinson\u2019s disease from essential tremor. J Neural Transm (Vienna) 2007,114(7),935-938","journal-title":"J Neural Transm (Vienna)"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1002\/1531-8257(199911)14:6<988:AID-MDS1012>3.0.CO;2-M","volume":"14","author":"Schwartz M.","year":"1999","unstructured":"Schwartz M.; Badarny S.; Gofman S.; Hocherman S.; Visuomotor performance in patients with essential tremor. Mov Disord 1999,14(6),988-993","journal-title":"Mov Disord"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/j.1468-1331.2009.02784.x","volume":"17","author":"Jim\u00e9nez-Jim\u00e9nez F.J.","year":"2010","unstructured":"Jim\u00e9nez-Jim\u00e9nez F.J.; Rubio L.; Alonso-Navarro H.; Calleja M.; Pilo-de-la-Fuente B.; Plaza-Nieto J.F.; Benito-Le\u00f3n J.; Garc\u00eda-Ruiz P.J.; Ag\u00fandez J.A.; Impairment of rapid repetitive finger movements and visual reaction time in patients with essential tremor. Eur J Neurol 2010,17(1),152-159","journal-title":"Eur J Neurol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1002\/mds.26630","volume":"31","author":"Pedrosa D.J.","year":"2016","unstructured":"Pedrosa D.J.; Nelles C.; Maier F.; Eggers C.; Burghaus L.; Fink G.R.; Wittmann M.; Timmermann L.; Time reproduction deficits in essential tremor patients. Mov Disord 2016,31(8),1234-1240","journal-title":"Mov Disord"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/j.1399-0004.2006.00600.x","volume":"69","author":"Lucotte G.","year":"2006","unstructured":"Lucotte G.; Lagarde J.P.; Funalot B.; Sokoloff P.; Linkage with the Ser9Gly DRD3 polymorphism in essential tremor families. Clin Genet 2006,69(5),437-440","journal-title":"Clin Genet"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"10753","DOI":"10.1073\/pnas.0508189103","volume":"103","author":"Jeanneteau F.","year":"2006","unstructured":"Jeanneteau F.; Funalot B.; Jankovic J.; Deng H.; Lagarde J.P.; Lucotte G.; Sokoloff P.; A functional variant of the dopamine D3 receptor is associated with risk and age-at-onset of essential tremor. Proc Natl Acad Sci USA 2006,103(28),10753-10758","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1002\/mds.22518","volume":"24","author":"Garc\u00eda-Mart\u00edn E.","year":"2009","unstructured":"Garc\u00eda-Mart\u00edn E.; Mart\u00ednez C.; Alonso-Navarro H.; Benito-Le\u00f3n J.; Puertas I.; Rubio L.; L\u00f3pez-Alburquerque T.; Ag\u00fandez J.A.; Jim\u00e9nez-Jim\u00e9nez F.J.; Dopamine receptor D3 (DRD3) genotype and allelic variants and risk for essential tremor. Mov Disord 2009,24(13),1910-1915","journal-title":"Mov Disord"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/ane.12148","volume":"128","author":"Jim\u00e9nez-Jim\u00e9nez F.J.","year":"2013","unstructured":"Jim\u00e9nez-Jim\u00e9nez F.J.; Alonso-Navarro H.; Garc\u00eda-Mart\u00edn E.; Lorenzo-Betancor O.; Pastor P.; Ag\u00fandez J.A.; Update on genetics of essential tremor. Acta Neurol Scand 2013,128(6),359-371","journal-title":"Acta Neurol Scand"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/j.jocn.2013.03.023","volume":"20","author":"Mao X.","year":"2013","unstructured":"Mao X.; Wang T.; Liu M.; Chang X.; Li N.; Gu Y.; Zhao D.; Liao Q.; Peng R.; Meta-analysis of the influence of DRD3 Ser9Gly variant on susceptibility for essential tremor. J Clin Neurosci 2013,20(12),1644-1649","journal-title":"J Clin Neurosci"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1212\/WNL.0000000000000211","volume":"82","author":"Kuhlenb\u00e4umer G.","year":"2014","unstructured":"Kuhlenb\u00e4umer G.; Hopfner F.; Deuschl G.; Genetics of essential tremor: meta-analysis and review. Neurology 2014,82(11),1000-1007","journal-title":"Neurology"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1080\/01616412.2016.1210355","volume":"38","author":"Jim\u00e9nez-Jim\u00e9nez F.J.","year":"2016","unstructured":"Jim\u00e9nez-Jim\u00e9nez F.J.; Garc\u00eda-Mart\u00edn E.; Alonso-Navarro H.; Lorenzo-Betancor O.; Ortega-Cubero S.; Pastor P.; Calleja M.; Ag\u00fandez J.A.; A family study of DRD3 rs6280, SLC1A2 rs3794087 and MAPT rs1052553 variants in essential tremor. Neurol Res 2016,38(10),880-887","journal-title":"Neurol Res"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.pharep.2014.11.008","volume":"67","author":"Ossowska K.","year":"2015","unstructured":"Ossowska K.; G\u0142owacka U.; Kosmowska B.; Wardas J.; Apomorphine enhances harmaline-induced tremor in rats. Pharmacol Rep 2015,67(3),435-441","journal-title":"Pharmacol Rep"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/WNF.0b013e31824687bf","volume":"35","author":"Herceg M.","year":"2012","unstructured":"Herceg M.; Nagy F.; P\u00e1l E.; Janszky J.; K\u00e9sm\u00e1rky I.; Komoly S.; Kov\u00e1cs N.; Pramipexole may be an effective treatment option in essential tremor. Clin Neuropharmacol 2012,35(2),73-76","journal-title":"Clin Neuropharmacol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/cns.12467","volume":"22","author":"Kosmowska B.","year":"2016","unstructured":"Kosmowska B.; Wardas J.; G\u0142owacka U.; Ananthan S.; Ossowska K.; Pramipexole at a low dose induces beneficial effect in the harmaline-induced model of essential tremor in rats. CNS Neurosci Ther 2016,22(1),53-62","journal-title":"CNS Neurosci Ther"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"A302","DOI":"10.1212\/WNL.56.1.4","volume":"56","author":"Rajput A.H.","year":"2001","unstructured":"Rajput A.H.; Hornykiewicz O.; Deng Y.; Birdi S.; Miyashita H.; Macaulay R.; Increased noradrenaline levels in essential tremor brain. Neurology 2001,56(Suppl. 3),A302","journal-title":"Neurology"},{"key":"ref=38","first-page":"10","volume":"90","author":"Barkhatova V.P.","year":"1990","unstructured":"Barkhatova V.P.; Ivanova-Smolenskaia I.A.; [Catecholamine metabolism in essential tremor]. Zh Nevropatol Psikhiatr Im S S Korsakova 1990,90(3),10-14","journal-title":"Zh Nevropatol Psikhiatr Im S S Korsakova"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1136\/jnnp.54.6.516","volume":"54","author":"van Hilten J.J.","year":"1991","unstructured":"van Hilten J.J.; van Dijk J.G.; Dunnewold R.J.; van der Velde E.A.; Kemp B.; van Brummelen P.; van der Krogt J.A.; Roos R.A.; Buruma O.J.; Diurnal variation of essential and physiological tremor. J Neurol Neurosurg Psychiatry 1991,54(6),516-519","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.33588\/rn.27160.98212","volume":"27","author":"Tapiador M.J.","year":"1998","unstructured":"Tapiador M.J.; P\u00e9rez L\u00f3pez-Fraile I.; L\u00f3pez-L\u00f3pez A.; Temblor esencial: una revisi\u00f3n sobre sus mecanismos patog\u00e9nicos. Rev Neurol 1998,27(160),1059-1065","journal-title":"Rev Neurol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1002\/mds.20908","volume":"21","author":"Lee P.H.","year":"2006","unstructured":"Lee P.H.; Kim J.W.; Bang O.Y.; Joo I.S.; Yoon S.N.; Huh K.; Cardiac 123I-MIBG scintigraphy in patients with essential tremor. Mov Disord 2006,21(8),1235-1238","journal-title":"Mov Disord"},{"key":"ref=42","first-page":"53","volume":"33","author":"Marsden C.D.","year":"1967","unstructured":"Marsden C.D.; Foley T.H.; Owen D.A.L.; McAllister R.G.; Peripheral beta-adrenergic receptors concerned with tremor. Clin Sci 1967,33(1),53-65","journal-title":"Clin Sci"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1136\/jnnp.42.10.904","volume":"42","author":"Jefferson D.","year":"1979","unstructured":"Jefferson D.; Jenner P.; Marsden C.D.; beta-Adrenoreceptor antagonists in essential tremor. J Neurol Neurosurg Psychiatry 1979,42(10),904-909","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1056\/NEJM197511062931902","volume":"293","author":"Young R.R.","year":"1975","unstructured":"Young R.R.; Growdon J.H.; Shahani B.T.; Beta-adrenergic mechanisms in action tremor. N Engl J Med 1975,293(19),950-953","journal-title":"N Engl J Med"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/S0140-6736(81)92276-5","volume":"1","author":"Leigh P.N.","year":"1981","unstructured":"Leigh P.N.; Marsden C.D.; Twomey A.; Jefferson D.; beta-Adrenoceptor antagonists and essential tremor. Lancet 1981,1(8229),1106","journal-title":"Lancet"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1136\/jnnp.47.11.1216","volume":"47","author":"Ter\u00e4v\u00e4inen H.","year":"1984","unstructured":"Ter\u00e4v\u00e4inen H.; Larsen T.A.; Adrenergic beta-receptor sensitivity in essential tremor. J Neurol Neurosurg Psychiatry 1984,47(11),1216-1218","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1097\/00002826-198904000-00009","volume":"12","author":"Koller W.C.","year":"1989","unstructured":"Koller W.C.; Tradozone in essential tremor. Probe of serotoninergic mechanisms. Clin Neuropharmacol 1989,12(2),134-137","journal-title":"Clin Neuropharmacol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.parkreldis.2012.04.024","volume":"18","author":"Gironell A.","year":"2012","unstructured":"Gironell A.; Figueiras F.P.; Pagonabarraga J.; Herance J.R.; Pascual-Sedano B.; Trampal C.; Gispert J.D.; Gaba and serotonin molecular neuroimaging in essential tremor: a clinical correlation study. Parkinsonism Relat Disord 2012,18(7),876-880","journal-title":"Parkinsonism Relat Disord"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1080\/01616412.2016.1275456","volume":"39","author":"Abdulrahman A.A.","year":"2017","unstructured":"Abdulrahman A.A.; Faisal K.; Meshref A.A.; Arshaduddin M.; Low-dose acute vanillin is beneficial against harmaline-induced tremors in rats. Neurol Res 2017,39(3),264-270","journal-title":"Neurol Res"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1177\/0269881111398685","volume":"26","author":"Zoethout R.W.","year":"2012","unstructured":"Zoethout R.W.; Iannone R.; Bloem B.R.; Palcza J.; Murphy G.; Chodakewitz J.; Buntinx A.; Gottesdiener K.; Marsilio S.; Rosen L.; van Dyck K.; Louis E.D.; Cohen A.F.; Schoemaker R.C.; Tokita S.; Sato N.; Koblan K.S.; Hargreaves R.H.; Renger J.; van Gerven J.M.; The effects of a novel histamine-3 receptor inverse agonist on essential tremor in comparison to stable levels of alcohol. J Psychopharmacol (Oxford) 2012,26(2),292-302","journal-title":"J Psychopharmacol (Oxford)"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/s12017-008-8040-3","volume":"10","author":"Ledesma M.C.","year":"2008","unstructured":"Ledesma M.C.; Garc\u00eda-Mart\u00edn E.; Alonso-Navarro H.; Mart\u00ednez C.; Jim\u00e9nez-Jim\u00e9nez F.J.; Benito-Le\u00f3n J.; Puertas I.; Rubio L.; L\u00f3pez-Alburquerque T.; Ag\u00fandez J.A.; The nonsynonymous Thr105Ile polymorphism of the histamine N-methyltransferase is associated to the risk of developing essential tremor. Neuromolecular Med 2008,10(4),356-361","journal-title":"Neuromolecular Med"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.parkreldis.2009.08.011","volume":"16","author":"Keeling B.H.","year":"2010","unstructured":"Keeling B.H.; Vilari\u00f1o-G\u00fcell C.; Soto-Ortolaza A.I.; Ross O.A.; Uitti R.J.; Rajput A.; Wszolek Z.K.; Farrer M.J.; Histamine N-methyltransferase Thr105Ile is not associated with Parkinson\u2019s disease or essential tremor. Parkinsonism Relat Disord 2010,16(2),112-114","journal-title":"Parkinsonism Relat Disord"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/1531-8249(199908)46:2<249:AID-ANA15>3.0.CO;2-C","volume":"46","author":"Pahapill P.A.","year":"1999","unstructured":"Pahapill P.A.; Levy R.; Dostrovsky J.O.; Davis K.D.; Rezai A.R.; Tasker R.R.; Lozano A.M.; Tremor arrest with thalamic microinjections of muscimol in patients with essential tremor. Ann Neurol 1999,46(2),249-252","journal-title":"Ann Neurol"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0304-3940(01)02166-8","volume":"312","author":"Tariq M.","year":"2001","unstructured":"Tariq M.; Arshaduddin M.; Biary N.; Al Moutaery K.; Al Deeb S.; Baclofen attenuates harmaline induced tremors in rats. Neurosci Lett 2001,312(2),79-82","journal-title":"Neurosci Lett"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1177\/0269881111415731","volume":"26","author":"de Haas S.L.","year":"2012","unstructured":"de Haas S.L.; Zoethout R.W.; Van Dyck K.; De Smet M.; Rosen L.B.; Murphy M.G.; Gottesdiener K.M.; Schoemaker R.C.; Cohen A.F.; van Gerven J.M.; The effects of TPA023, a GABAA\u03b12,3 subtype-selective partial agonist, on essential tremor in comparison to alcohol. J Psychopharmacol (Oxford) 2012,26(2),282-291","journal-title":"J Psychopharmacol (Oxford)"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/0091-3057(91)90190-D","volume":"39","author":"M\u00e1lly J.","year":"1991","unstructured":"M\u00e1lly J.; Stone T.W.; The effect of theophylline on essential tremor: the possible role of GABA. Pharmacol Biochem Behav 1991,39(2),345-349","journal-title":"Pharmacol Biochem Behav"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/BF01273153","volume":"103","author":"M\u00e1lly J.","year":"1996","unstructured":"M\u00e1lly J.; Baranyi M.; Vizi E.S.; Change in the concentrations of amino acids in CSF and serum of patients with essential tremor. J Neural Transm (Vienna) 1996,103(5),555-560","journal-title":"J Neural Transm (Vienna)"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/brain\/awr301","volume":"135","author":"Paris-Robidas S.","year":"2012","unstructured":"Paris-Robidas S.; Brochu E.; Sintes M.; Emond V.; Bousquet M.; Vandal M.; Pilote M.; Tremblay C.; Di Paolo T.; Rajput A.H.; Rajput A.; Calon F.; Defective dentate nucleus GABA receptors in essential tremor. Brain 2012,135(Pt 1),105-116","journal-title":"Brain"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.jocn.2011.11.001","volume":"19","author":"Luo C.","year":"2012","unstructured":"Luo C.; Rajput A.H.; Robinson C.A.; Rajput A.; Gamma-aminobutyric acid (GABA)-B receptor 1 in cerebellar cortex of essential tremor. J Clin Neurosci 2012,19(6),920-921","journal-title":"J Clin Neurosci"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.2967\/jnumed.109.074120","volume":"51","author":"Boecker H.","year":"2010","unstructured":"Boecker H.; Weindl A.; Brooks D.J.; Ceballos-Baumann A.O.; Liedtke C.; Miederer M.; Sprenger T.; Wagner K.J.; Miederer I.; GABAergic dysfunction in essential tremor: an 11C-flumazenil PET study. J Nucl Med 2010,51(7),1030-1035","journal-title":"J Nucl Med"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s12311-017-0891-4","volume":"17","author":"Louis E.D.","year":"2018","unstructured":"Louis E.D.; Hernandez N.; Dyke J.P.; Ma R.E.; Dydak U.; \n                        In vivo dentate nucleus gamma-aminobutyric acid concentration in essential tremor vs. controls. Cerebellum 2018,17(2),165-172","journal-title":"Cerebellum"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1172\/JCI200523625","volume":"115","author":"Kralic J.E.","year":"2005","unstructured":"Kralic J.E.; Criswell H.E.; Osterman J.L.; O\u2019Buckley T.K.; Wilkie M.E.; Matthews D.B.; Hamre K.; Breese G.R.; Homanics G.E.; Morrow A.L.; Genetic essential tremor in gamma-aminobutyric acidA receptor alpha1 subunit knockout mice. J Clin Invest 2005,115(3),774-779","journal-title":"J Clin Invest"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.neulet.2006.02.066","volume":"401","author":"Deng H.","year":"2006","unstructured":"Deng H.; Xie W.J.; Le W.D.; Huang M.S.; Jankovic J.; Genetic analysis of the GABRA1 gene in patients with essential tremor. Neurosci Lett 2006,401(1-2),16-19","journal-title":"Neurosci Lett"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s00415-010-5708-z","volume":"258","author":"Garc\u00eda-Mart\u00edn E.","year":"2011","unstructured":"Garc\u00eda-Mart\u00edn E.; Mart\u00ednez C.; Alonso-Navarro H.; Benito-Le\u00f3n J.; Lorenzo-Betancor O.; Pastor P.; Puertas I.; Rubio L.; L\u00f3pez-Alburquerque T.; Ag\u00fandez J.A.; Jim\u00e9nez-Jim\u00e9nez F.J.; Gamma-aminobutyric acid (GABA) receptor rho (GABRR) polymorphisms and risk for essential tremor. J Neurol 2011,258(2),203-211","journal-title":"J Neurol"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1097\/FPC.0b013e328345bec0","volume":"21","author":"Garc\u00eda-Mart\u00edn E.","year":"2011","unstructured":"Garc\u00eda-Mart\u00edn E.; Mart\u00ednez C.; Alonso-Navarro H.; Benito-Le\u00f3n J.; Lorenzo-Betancor O.; Pastor P.; Puertas I.; Rubio L.; L\u00f3pez-Alburquerque T.; Ag\u00fandez J.A.; Jim\u00e9nez-Jim\u00e9nez F.J.; Gamma-aminobutyric acid GABRA4, GABRE, and GABRQ receptor polymorphisms and risk for essential tremor. Pharmacogenet Genomics 2011,21(7),436-439","journal-title":"Pharmacogenet Genomics"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1111\/j.1468-1331.2010.03308.x","volume":"18","author":"Thier S.","year":"2011","unstructured":"Thier S.; Kuhlenb\u00e4umer G.; Lorenz D.; Nothnagel M.; Nebel A.; Christensen K.; Schreiber S.; Deuschl G.; Klebe S.; GABA(A) receptor- and GABA transporter polymorphisms and risk for essential tremor. Eur J Neurol 2011,18(8),1098-1100","journal-title":"Eur J Neurol"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/ejhg.2015.228","volume":"24","author":"Liu X.","year":"2016","unstructured":"Liu X.; Hernandez N.; Kisselev S.; Floratos A.; Sawle A.; Ionita-Laza I.; Ottman R.; Louis E.D.; Clark L.N.; Identification of candidate genes for familial early-onset essential tremor. Eur J Hum Genet 2016,24(7),1009-1015","journal-title":"Eur J Hum Genet"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s00439-016-1709-z","volume":"135","author":"Tio M.","year":"2016","unstructured":"Tio M.; Wen R.; Lim Y.L.; Wang H.; Ling S.C.; Zhao Y.; Tan E.K.; FUS-linked essential tremor associated with motor dysfunction in Drosophila. Hum Genet 2016,135(11),1223-1232","journal-title":"Hum Genet"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/mds.25809","volume":"29","author":"Chuang W.L.","year":"2014","unstructured":"Chuang W.L.; Huang Y.Z.; Lu C.S.; Chen R.S.; Reduced cortical plasticity and GABAergic modulation in essential tremor. Mov Disord 2014,29(4),501-507","journal-title":"Mov Disord"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s40478-014-0157-z","volume":"2","author":"Lee M.","year":"2014","unstructured":"Lee M.; Cheng M.M.; Lin C.Y.; Louis E.D.; Faust P.L.; Kuo S.H.; Decreased EAAT2 protein expression in the essential tremor cerebellar cortex. Acta Neuropathol Commun 2014,2,157","journal-title":"Acta Neuropathol Commun"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.parkreldis.2016.09.003","volume":"32","author":"Wang J.","year":"2016","unstructured":"Wang J.; Kelly G.C.; Tate W.J.; Li Y.S.; Lee M.; Gutierrez J.; Louis E.D.; Faust P.L.; Kuo S.H.; Excitatory Amino acid transporter expression in the essential tremor dentate nucleus and cerebellar cortex: A postmortem study. Parkinsonism Relat Disord 2016,32,87-93","journal-title":"Parkinsonism Relat Disord"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1093\/brain\/awu281","volume":"137","author":"Lin C.Y.","year":"2014","unstructured":"Lin C.Y.; Louis E.D.; Faust P.L.; Koeppen A.H.; Vonsattel J.P.; Kuo S.H.; Abnormal climbing fibre-Purkinje cell synaptic connections in the essential tremor cerebellum. Brain 2014,137(Pt 12),3149-3159","journal-title":"Brain"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0304-3940(02)00966-7","volume":"333","author":"Louis E.D.","year":"2002","unstructured":"Louis E.D.; Shungu D.C.; Chan S.; Mao X.; Jurewicz E.C.; Watner D.; Metabolic abnormality in the cerebellum in patients with essential tremor: a proton magnetic resonance spectroscopic imaging study. Neurosci Lett 2002,333(1),17-20","journal-title":"Neurosci Lett"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1212\/01.WNL.0000065885.15875.0D","volume":"60","author":"Pagan F.L.","year":"2003","unstructured":"Pagan F.L.; Butman J.A.; Dambrosia J.M.; Hallett M.; Evaluation of essential tremor with multi-voxel magnetic resonance spectroscopy. Neurology 2003,60(8),1344-1347","journal-title":"Neurology"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1002\/mds.20019","volume":"19","author":"Louis E.D.","year":"2004","unstructured":"Louis E.D.; Shungu D.C.; Mao X.; Chan S.; Jurewicz E.C.; Cerebellar metabolic symmetry in essential tremor studied with 1H magnetic resonance spectroscopic imaging: implications for disease pathology. Mov Disord 2004,19(6),672-677","journal-title":"Mov Disord"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.parkreldis.2017.11.345","volume":"47","author":"Barbagallo G.","year":"2018","unstructured":"Barbagallo G.; Arabia G.; Novellino F.; Nistic\u00f2 R.; Salsone M.; Morelli M.; Rocca F.; Quattrone A.; Caracciolo M.; Sabatini U.; Cherubini A.; Quattrone A.; Increased glutamate\u00a0+ glutamine levels in the thalamus of patients with essential tremor: A preliminary proton MR spectroscopic study. Parkinsonism Relat Disord 2018,47,57-63","journal-title":"Parkinsonism Relat Disord"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/j.1468-1331.2008.02150.x","volume":"15","author":"Manto M.","year":"2008","unstructured":"Manto M.; Laute M.A.; A possible mechanism for the beneficial effect of ethanol in essential tremor. Eur J Neurol 2008,15(7),697-705","journal-title":"Eur J Neurol"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ejphar.2012.08.014","volume":"695","author":"Rahimi Shourmasti F.","year":"2012","unstructured":"Rahimi Shourmasti F.; Goudarzi I.; Lashkarbolouki T.; Abrari K.; Elahdadi Salmani M.; Goudarzi A.; Effects of riluzole on harmaline induced tremor and ataxia in rats: biochemical, histological and behavioral studies. Eur J Pharmacol 2012,695(1-3),40-47","journal-title":"Eur J Pharmacol"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.neulet.2015.01.078","volume":"590","author":"Vaziri Z.","year":"2015","unstructured":"Vaziri Z.; Abbassian H.; Sheibani V.; Haghani M.; Nazeri M.; Aghaei I.; Shabani M.; The therapeutic potential of Berberine chloride hydrate against harmaline-induced motor impairments in a rat model of tremor. Neurosci Lett 2015,590,84-90","journal-title":"Neurosci Lett"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.neuropharm.2014.03.018","volume":"83","author":"Ossowska K.","year":"2014","unstructured":"Ossowska K.; Wardas J.; Berghauzen-Maciejewska K.; G\u0142owacka U.; Kuter K.; Pilc A.; Zorn S.H.; Doller D.; Lu AF21934, a positive allosteric modulator of mGlu4 receptors, reduces the harmaline-induced hyperactivity but not tremor in rats. Neuropharmacology 2014,83,28-35","journal-title":"Neuropharmacology"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1212\/WNL.0b013e31825fdeed","volume":"79","author":"Thier S.","year":"2012","unstructured":"Thier S.; Lorenz D.; Nothnagel M.; Poremba C.; Papengut F.; Appenzeller S.; Paschen S.; Hofschulte F.; Hussl A.C.; Hering S.; Poewe W.; Asmus F.; Gasser T.; Sch\u00f6ls L.; Christensen K.; Nebel A.; Schreiber S.; Klebe S.; Deuschl G.; Kuhlenb\u00e4umer G.; Polymorphisms in the glial glutamate transporter SLC1A2 are associated with essential tremor. Neurology 2012,79(3),243-248","journal-title":"Neurology"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1097\/FPC.0000000000000171","volume":"25","author":"Jim\u00e9nez-Jim\u00e9nez F.J.","year":"2015","unstructured":"Jim\u00e9nez-Jim\u00e9nez F.J.; Alonso-Navarro H.; Garc\u00eda-Mart\u00edn E.; Ag\u00fandez J.A.; SLC1A2 rs3794087 variant and risk for essential tremor: a systematic review and meta-analysis. Pharmacogenet Genomics 2015,25(11),564-568","journal-title":"Pharmacogenet Genomics"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.neulet.2017.12.045","volume":"666","author":"Cheng Y.","year":"2018","unstructured":"Cheng Y.; Mao C.Y.; Liu Y.T.; Li F.; Yang J.; Liu H.; Zhang C.; Wang Y.L.; Wu J.; Shi C.H.; Xu Y.M.; Analysis of variant rs3794087 in SLC1A2 and Parkinson\u2019s disease in a Chinese Han population: A case-control study and meta-analysis. Neurosci Lett 2018,666,165-168","journal-title":"Neurosci Lett"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/nm1693","volume":"14","author":"Bekar L.","year":"2008","unstructured":"Bekar L.; Libionka W.; Tian G.F.; Xu Q.; Torres A.; Wang X.; Lovatt D.; Williams E.; Takano T.; Schnermann J.; Bakos R.; Nedergaard M.; Adenosine is crucial for deep brain stimulation-mediated attenuation of tremor. Nat Med 2008,14(1),75-80","journal-title":"Nat Med"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.mayocp.2012.05.006","volume":"87","author":"Chang S.Y.","year":"2012","unstructured":"Chang S.Y.; Kim I.; Marsh M.P.; Jang D.P.; Hwang S.C.; Van Gompel J.J.; Goerss S.J.; Kimble C.J.; Bennet K.E.; Garris P.A.; Blaha C.D.; Lee K.H.; Wireless fast-scan cyclic voltammetry to monitor adenosine in patients with essential tremor during deep brain stimulation. Mayo Clin Proc 2012,87(8),760-765","journal-title":"Mayo Clin Proc"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/cns.12692","volume":"23","author":"Kosmowska B.","year":"2017","unstructured":"Kosmowska B.; Ossowska K.; G\u0142owacka U.; Wardas J.; Tremorolytic effect of 5\u2032-chloro-5\u2032-deoxy-(\u00b1)-ENBA, a potent and selective adenosine A1 receptor agonist, evaluated in the harmaline-induced model in rats. CNS Neurosci Ther 2017,23(5),438-446","journal-title":"CNS Neurosci Ther"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"10731","DOI":"10.1073\/pnas.1002995107","volume":"107","author":"Park Y.G.","year":"2010","unstructured":"Park Y.G.; Park H.Y.; Lee C.J.; Choi S.; Jo S.; Choi H.; Kim Y.H.; Shin H.S.; Llinas R.R.; Kim D.; Ca(V)3.1 is a tremor rhythm pacemaker in the inferior olive. Proc Natl Acad Sci USA 2010,107(23),10731-10736","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.neuropharm.2010.05.012","volume":"59","author":"Handforth A.","year":"2010","unstructured":"Handforth A.; Homanics G.E.; Covey D.F.; Krishnan K.; Lee J.Y.; Sakimura K.; Martin F.C.; Quesada A.; T-type calcium channel antagonists suppress tremor in two mouse models of essential tremor. Neuropharmacology 2010,59(6),380-387","journal-title":"Neuropharmacology"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.bbrc.2011.05.082","volume":"410","author":"Chang K.Y.","year":"2011","unstructured":"Chang K.Y.; Park Y.G.; Park H.Y.; Homanics G.E.; Kim J.; Kim D.; Lack of CaV3.1 channels causes severe motor coordination defects and an age-dependent cerebellar atrophy in a genetic model of essential tremor. Biochem Biophys Res Commun 2011,410(1),19-23","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/ng.299","volume":"41","author":"Stefansson H.","year":"2009","unstructured":"Stefansson H.; Steinberg S.; Petursson H.; Gustafsson O.; Gudjonsdottir I.H.; Jonsdottir G.A.; Palsson S.T.; Jonsson T.; Saemundsdottir J.; Bjornsdottir G.; B\u00f6ttcher Y.; Thorlacius T.; Haubenberger D.; Zimprich A.; Auff E.; Hotzy C.; Testa C.M.; Miyatake L.A.; Rosen A.R.; Kristleifsson K.; Rye D.; Asmus F.; Sch\u00f6ls L.; Dichgans M.; Jakobsson F.; Benedikz J.; Thorsteinsdottir U.; Gulcher J.; Kong A.; Stefansson K.; Variant in the sequence of the LINGO1 gene confers risk of essential tremor. Nat Genet 2009,41(3),277-279","journal-title":"Nat Genet"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jns.2012.02.030","volume":"317","author":"Jim\u00e9nez-Jim\u00e9nez F.J.","year":"2012","unstructured":"Jim\u00e9nez-Jim\u00e9nez F.J.; Garc\u00eda-Mart\u00edn E.; Lorenzo-Betancor O.; Pastor P.; Alonso-Navarro H.; Ag\u00fandez J.A.; LINGO1 and risk for essential tremor: results of a meta-analysis of rs9652490 and rs11856808. J Neurol Sci 2012,317(1-2),52-57","journal-title":"J Neurol Sci"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s00401-013-1108-7","volume":"125","author":"Kuo S.H.","year":"2013","unstructured":"Kuo S.H.; Tang G.; Louis E.D.; Ma K.; Babji R.; Balatbat M.; Cortes E.; Vonsattel J.P.; Yamamoto A.; Sulzer D.; Faust P.L.; Lingo-1 expression is increased in essential tremor cerebellum and is present in the basket cell pinceau. Acta Neuropathol 2013,125(6),879-889","journal-title":"Acta Neuropathol"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1002\/mds.25819","volume":"29","author":"Delay C.","year":"2014","unstructured":"Delay C.; Tremblay C.; Brochu E.; Paris-Robidas S.; Emond V.; Rajput A.H.; Rajput A.; Calon F.; Increased LINGO1 in the cerebellum of essential tremor patients. Mov Disord 2014,29(13),1637-1647","journal-title":"Mov Disord"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1517\/14728222.2015.1028360","volume":"19","author":"Ag\u00fandez J.A.","year":"2015","unstructured":"Ag\u00fandez J.A.; Jim\u00e9nez-Jimenez F.J.; Alonso-Navarro H.; Garc\u00eda-Mart\u00edn E.; The potential of LINGO-1 as a therapeutic target for essential tremor. Expert Opin Ther Targets 2015,19(8),1139-1148","journal-title":"Expert Opin Ther Targets"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1177\/1756285616679123","volume":"10","author":"Hedera P.","year":"2017","unstructured":"Hedera P.; Emerging strategies in the management of essential tremor. Ther Adv Neurol Disorder 2017,10(2),137-148","journal-title":"Ther Adv Neurol Disorder"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"3196","DOI":"10.1111\/bph.13581","volume":"173","author":"Abbassian H.","year":"2016","unstructured":"Abbassian H.; Whalley B.J.; Sheibani V.; Shabani M.; Cannabinoid type 1 receptor antagonism ameliorates harmaline-induced essential tremor in rat. Br J Pharmacol 2016,173(22),3196-3207","journal-title":"Br J Pharmacol"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"314-320","DOI":"10.1016\/j.physbeh.2016.06.013","volume":"164","author":"Abbassian H.","year":"2016","unstructured":"Abbassian H.; Esmaeili P.; Tahamtan M.; Aghaei I.; Vaziri Z.; Sheibani V.; Whalley B.J.; Shabani M.; Cannabinoid receptor agonism suppresses tremor, cognition disturbances and anxiety-like behaviors in a rat model of essential tremor. Physiol Behav 2016,164(Pt A),314-320","journal-title":"Physiol Behav"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.neulet.2017.06.015","volume":"653","author":"Dahmardeh N.","year":"2017","unstructured":"Dahmardeh N.; Asadi-Shekaari M.; Arjmand S.; Kalantaripour T.; Basiri M.; Shabani M.; Modulation of sphingosine-1-phosphate receptor ameliorates harmaline-induced essential tremor in rat. Neurosci Lett 2017,653,376-381","journal-title":"Neurosci Lett"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s11011-016-9834-x","volume":"31","author":"Stroh M.A.","year":"2016","unstructured":"Stroh M.A.; Winter M.K.; Swerdlow R.H.; McCarson K.E.; Zhu H.; Loss of NCB5OR in the cerebellum disturbs iron pathways, potentiates behavioral abnormalities, and exacerbates harmaline-induced tremor in mice. Metab Brain Dis 2016,31(4),951-964","journal-title":"Metab Brain Dis"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1002\/mds.20940","volume":"21","author":"Martin F.C.","year":"2006","unstructured":"Martin F.C.; Handforth A.; Carbenoxolone and mefloquine suppress tremor in the harmaline mouse model of essential tremor. Mov Disord 2006,21(10),1641-1649","journal-title":"Mov Disord"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s007020050036","volume":"105","author":"Eder U.","year":"1998","unstructured":"Eder U.; Leitner B.; Kirchmair R.; Pohl P.; Jobst K.A.; Smith A.D.; M\u00e1lly J.; Benzer A.; Riederer P.; Reichmann H.; Saria A.; Winkler H.; Levels and proteolytic processing of chromogranin A and B and secretogranin II in cerebrospinal fluid in neurological diseases. J Neural Transm (Vienna) 1998,105(1),39-51","journal-title":"J Neural Transm (Vienna)"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"110","DOI":"10.2174\/9781608057757113020007","volume":"Vol. 2","author":"Alonso-Navarro H.","year":"2013","unstructured":"Alonso-Navarro H.; Jim\u00e9nez-Jim\u00e9nez F.J.; Garc\u00eda-Mart\u00edn E.; Ag\u00fandez J.A.G.;  Frontiers in Clinical Drug Research - CNS and Neurological Disorders 2013,Vol. 2,110-142","journal-title":"Frontiers in Clinical Drug Research - CNS and Neurological Disorders"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/167229","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T03:17:52Z","timestamp":1586834272000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/167229\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,27]]},"references-count":102,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,3,27]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867325666181112094330","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3,27]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-04-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-09-03","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-11-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-03-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}